Natural Killer T cells Balancing the Regulation of Tumor Immunity /

Natural killer T (NKT) cells are CD1d-restricted T cells that respond to lipid, not protein, antigens presented by CD1d, which is a non-classical MHC class I-like molecule.  This relatively small but pivotal T cell population bridges the gap between innate and adaptive immunity by rapidly produce la...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Terabe, Masaki (Επιμελητής έκδοσης), Berzofsky, Jay A. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New York, NY : Springer New York, 2012.
Έκδοση:1.
Σειρά:Cancer Drug Discovery and Development
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Preface.-  Introduction: Mechanisms of NKT cell-mediated adjuvant activity and function of iPS-derived NKT cells
  • Structure and Recognition of Antigens for Invariant NKT Cells
  • Invariant NKT cell-based vaccine strategies
  • Immune regulation of tumor immunity by NKT cells
  • The Regulation of CD1d+ and CD1d- tumors by NKT Cells
  • DC-based immunotherapy targeting NKT cells
  • Therapeutic Approaches Utilising NKT Cells
  • NKT Cells of Cancer Patients & How Models can Inform Therapeutic Plans
  • Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges
  • Clinical trials with α-galactosylceramide (KRN7000) in advanced cancer
  • Clinical trials of invariant Natural Killer T cell-based immunotherapy for cancer
  • Index.  .